Dr. Benjamin Saltman, MD

Dr. Saltman practices at Sharp Rees-Stealy Medical Group, Inc in San Diego, California.

Dr. Saltman's NPI, 1568585891, was assigned on April 10, 2007. Dr. Saltman graduated from University Of Michigan Medical School in 2002. Dr. Saltman holds California license C142543.

Dr. Saltman's primary practice is Sharp Rees-Stealy Medical Group, Inc, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (858) 262-6666.

Dr. Saltman's primary practice is Sharp Rees-Stealy Medical Group, Inc in San Diego, California. Dr. Saltman is also affiliated with Sharp Memorial Hospital. The medical group on file is Sharp Rees-Stealy Medical Group. Dmand AI also links Dr. Saltman to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Saltman practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Saltman's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Saltman is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Saltman's licenses on file in 2 states: California and New York.

Dmand AI lists thyroid surgery among the conditions Dr. Saltman treats.

CMS data shows 135 Medicare services from Dr. Saltman across 5 procedure codes in 2024, for 101 Medicare patients. Medicare paid $12,405 for them. Every service was in an office.

CMS counts 101 Medicare patients who saw Dr. Saltman in 2024. The largest group is 65 to 74, with 49 patients. 66% of them have high blood pressure, and 66% have high cholesterol. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Saltman's median patient age at 64, with 51% women.

In 2024, Dr. Saltman wrote 49 Medicare Part D claims for 25 patients. 100% of them were for generic drugs. They cover 2 drugs, with $4,620 in total drug cost. In 2018, CMS named 41 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Saltman for performance year 2024, reported as part of a group. Dr. Saltman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Saltman as offering telehealth. CMS counts 28 procedures of melanoma (skin cancer) excision by Dr. Saltman, more than 79% of the clinicians it reports for that procedure.

Dmand AI links 10 papers to Dr. Saltman, published from 2009 to 2015. The most frequent topics are Predictive Value of Tests, Vocal Cords and Biomarkers, Tumor. Dr. Saltman has published most often in Head Neck. Dr. Saltman's most frequent co-authors are Ronald A. Ghossein, MD, Snehal G. Patel, MBBS and Mary S. Brady, MD.

CMS Open Payments shows 13 general payments to Dr. Saltman from 8 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 76% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $8,190.

Dmand AI lists 1 award for Dr. Saltman.

Dr. Saltman graduated from University Of Michigan Medical School in 2002. Dr. Saltman is a member of ACS.

Dr. Saltman is in network with 6 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.